Management and resources for clinical trials in cancer treatment
Core C: Clinical Management and Resources
This study is all about helping people with cancer by testing new vaccines made from special immune cells, and if you join, you'll get access to the latest treatments while we carefully track how well they work for you.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project ID | NIH-10916170 on NIH RePORTER |
What this research studies
This research focuses on providing comprehensive support and coordination for clinical trials aimed at developing dendritic cell vaccines for cancer treatment. It involves overseeing the production and distribution of these vaccines, monitoring patients' immune responses, and collecting clinical data to ensure the trials are conducted efficiently and meet regulatory standards. Patients participating in these trials will receive cutting-edge therapies and be closely monitored for their responses, contributing to the advancement of cancer treatment. The research aims to integrate various clinical components to enhance the effectiveness of the trials.
Who could benefit from this research
Good fit: Ideal candidates for participation are patients diagnosed with cancer who are eligible for clinical trials involving dendritic cell therapies.
Not a fit: Patients with non-cancerous conditions or those who do not meet the eligibility criteria for the clinical trials may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatments through the development of effective dendritic cell vaccines.
How similar studies have performed: Previous research has shown promise in using dendritic cell vaccines for cancer treatment, indicating that this approach has potential based on earlier successes.
Where this research is happening
Buffalo, United States
- Roswell Park Cancer Institute Corp — Buffalo, United States (Active)
Researchers
- Principal investigator: Puzanov, Igor — Roswell Park Cancer Institute Corp
- Study coordinator: Puzanov, Igor
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.